PPI deficit induced by amphetamine is attenuated by the histamine H 1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin

Psychopharmacology

Volumn 212, Issue 4, 2010, Pages 551-558

  Larrauri, José A ^a   Levin, Edward D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Amphetamine; Dopamine; Histamine; Ketanserin; PPI; Prepulse inhibition; Pyrilamine; Serotonin

Indexed keywords

AMPHETAMINE; HISTAMINE RECEPTOR; KETANSERIN TARTRATE; MEPYRAMINE MALEATE; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; FEMALE; NEUROLOGIC DISEASE; NEUROMODULATION; NOISE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; SENSORY GATING; SOUND INTENSITY; STARTLE REFLEX; TACTILE DISCRIMINATION;

ACOUSTIC STIMULATION; AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HISTAMINE H1 ANTAGONISTS; INHIBITION (PSYCHOLOGY); KETANSERIN; PHYSICAL STIMULATION; PYRILAMINE; RATS; RATS, SPRAGUE-DAWLEY; SENSORY GATING; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; STARTLE REACTION;

EID: 78651331271     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-2005-6     Document Type: Article

References (45)

1. Bakshi VP, Swerdlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787-794
2. Bortolato M, Aru GN, Fa M, Frau R, Orru M, Salis P et al (2005) Activation of D1, but not D2 receptor potentiates dizocilpinemediated disruption of prepulse inhibition of the startle. Neuropsychopharmacol 30:561-574 (Pubitemid 40271158)
3. Braff DL, Stone C, Callaway E, Geyer MA, Glick I, Bali L (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339-343
4. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: Normal subjects, patients groups, and pharmacological studies. Psychopharmacology 156:234-258
5. Browman KE, Komater VA, Curzon P, Rueter LE, Hancock AA, Decker MW, Fox GB (2004) Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan. Behav Brain Res 153:69-76
6. Bubenikova T, Votava M, Horacek J, Palenicek T, Dockery C (2005) The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating. Pharmacol Biochem Behav 80:591-596
7. Caceda R, Kinkead B, Owens MJ, Nemeroff CB (2005) Virally mediated increased neurotensin 1 receptor in the nucleus accumbens decreases behavioral effects of mesolimbic system activation. J Neurosci 25:11748-11756
8. Classen W, Laux G (1988) Sensorimotor and cognitive performance of schizophrenic inpatients treated with haloperidol, flupenthixol, or clozapine. Pharmacopsychiatry 21:295-297
9. Conti LH, Costill JE, Flynn S, Tayler JE (2005) Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotrophin-releasing factor and by rat strain. Behav Neurosci 119:1052-1060
10. Coward DM (1992) General pharmacology of clozapine. Brit J Psychiat 160:5-11
11. 1 receptor gene knockout mice. Psychopharmacology 183:285-293
12. De Belleroche JS, Gardiner IM (1982) Contrasting effects of 5- hydroxytryptamine on the release of dopamine and acetylcholine in the nucleus accumbens of rat. J Neural Transm 55:227-242
13. 1-receptor blockade. Neuropharmacology 40:624-633
14. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review. Psychopharmacology 156:117-154
15. Geyer MA, Krebs-Thomson K, Varty GB (1999) The effects of M100907 in pharmacological and developmental animal models of prepulse inhibition deficits in schizophrenia. Neuropsychopharmacol 21:S134-S142
16. Goldberg TE, Greenberg RD, Griffin SJ, Gold JM, Kleinman JE, Pickar D et al (1993) The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Brit J Psychiat 162:43-48
17. Graham FK (1975) The more or less startling effects of weak prestimulation. Psychophysiology 12:238-248
18. Guan XM, McBride WJ (1989) Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res Bull 23:541-547
19. Hoffman HS, Searle JL (1968) Acoustic and temporal factors in the evocation of startle. J Acoust Soc Am 43:269-282
20. Johansson C, Jackson DM, Zhang J, Svensson L (1995) Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: Effects of antipsychotics and other agents in rats. Pharmacol Biochem Behav 52:649-654
21. KochM(1999) The neurobiology of startle. Prog Neurobiol 59:107-128
22. Kumari V, Sharma T (2002) Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology 162:97-101
23. Le Pen G, Moreau JL (2002) Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: Reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacol 27:1-11
24. Levin ED, Caldwell DP, Perraut C (2007) Clozapine treatment reverses dizocilpine-induced deficits of pre-pulse inhibition of tactile startle response. Pharmacol Biochem Behav 86:597-605
25. Levin ED, Perkins A, Brotherton T, Qazi M, Berez C, Montalvo-Ortiz J, Davis K, Williams P, Christopher NC (2009) Chronic underactivity of medial frontal cortical ß2-containing nicotinic receptors increases clozapine-induced working memory impairment in female rats. Prog Neuro-Psychopharmacol 33:296-302
26. Mansbach RS, Geyer MA (1989) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacol 2:299-308
27. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94:507-514
28. McGurk SR (1999) The effects of clozapine on cognitive functioning in schizophrenia. J Clin Psychiatry 60:24-29
29. Meltzer HY, McGurk SR (1999) The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bull 25:233-256
30. Onodera K, Yamatodani A, Watanabe T, Wada H (1994) Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog Neurobiol 42:685-702
31. Panula P, Yang HYT, Costa E (1984) Histamine containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA 81:2572-2576
32. Pocivavsek A, Icenogle L, Levin ED (2006) Hippocampal α7 and α4β2 nicotinic receptors and clozapine effects on memory. Psychopharmacology 188:596-604
33. 1 receptor involvement in prepulse inhibition and memory function: Relevance for the antipsychotic actions of clozapine. Pharmacol Biochem Behav 86:686-692
34. Schwarzkopf SB, Bruno JP, Mitrab T (1993) Effects of haloperidol and SCH 23390 on acoustic startle and prepulse inhibition under basal and stimulated conditions. Prog Neuro-Psychopharmacol 17:1023-1036
35. Sills TL (1999) Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window. Brain Res Bull 48:445-448
36. Sipes TA, Geyer MA (1994) Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 33:441-448
37. Snedecor GW, Cochran WG (1967) Statistical methods. Iowa State University Press, Iowa
38. Sutherland JE, Page ME, Conti LH (2008) The effect of corticotropinreleasing factor on prepulse inhibition is independent of serotonin in Brown Norway and Wistar-Kyoto rats. Pharmacol Biochem Behav 89:324-337
39. Swerdlow NR, Geyer MA (1993) Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav 44:741-744
40. Swerdlow NR, Benbow CH, Zisook S, Geyer MA, Braff DL (1993) A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry 33:298-301
41. Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR (1995) Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry 58:182-200
42. Swerdlow NR, Kuczenski R, Goins JC, Crain SK, Ma LT, Bongiovanni MJ, Shoemaker JM (2005) Neurochemical analysis of rat strain differences in the startle gating-disruptive effects of dopamine agonists. Pharmacol Biochem Behav 80:203-211
43. Tenn CC, Fletcher PJ, Kapur SA (2005) A putative animal model of the "prodronal" state of schizophrenia. Biol Psychiatry 57:586-593
44. Varty GB, Higgins GA (1995) Reversal of a dizocilpine-induced disruption of prepulse inhibition of an acoustic startle response by the 5-HT2 receptor antagonist ketanserin. Eur J Pharmacol 287:201-205
45. Wan FJ, Swerdlow NR (1993) Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology 113:103-109